ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Progenics' Azedra becomes first FDA-approved treatment for adrenal tumours
August 02, 2018The FDA has approved its first-ever drug for rare, unresectable tumours of the adrenal gland with its decision to authorise Progenics Pharmaceuticals’ radiotherapeutic product Azedra (iobenguane I 131) in the treatment of pheochromocytoma or paraganglioma
Pharma Sources Insight January 2025
